Data gathered: October 27
AI Stock Analysis - Resmed (RMD)
Analysis generated September 10, 2025. Powered by Chat GPT.
Resmed is a global leader in the development and manufacturing of medical devices and cloud-connected software applications aimed at improving the quality of life for the people who suffer from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company has a strong commitment to research and development, enabling it to continually innovate and offer advanced solutions in its field.
Stock Alerts - Resmed (RMD)
 |
Resmed | October 14 Employee Rating is down by 2.4% over the last month. |
|
Resmed | October 10 Insider Alert: Farrell Michael J. is selling shares |
|
Resmed | October 4 Insider Alert: Sandercock Brett is selling shares |
|
Resmed | October 4 Employee Rating is up by 2.4% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Resmed
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 440 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,810,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 840 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 795 | Sign up | Sign up | Sign up |
| Facebook Followers | 167,430 | Sign up | Sign up | Sign up |
| Instagram Followers | 9,511 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 13 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,039 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,903 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 55,100 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 75 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,478 | Sign up | Sign up | Sign up |
About Resmed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Price | $259.21 |
| Target Price | Sign up |
| Volume | 1,230,000 |
| Market Cap | $37.9B |
| Year Range | $203.67 - $293.73 |
| Dividend Yield | 0.8% |
| PE Ratio | 27.31 |
| Analyst Rating | 50% buy |
| Earnings Date | October 30 '25 |
| Industry | Medical Devices |
In the news
 |
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseOctober 23 - Yahoo |
 |
Resmed AirSense 11 AutoSet CPAP Machine with Mask $1488 ($1413.60 new customer with code) Free Delivery @ CPAP ClubOctober 22 - Ozbargain.com.au |
Morgan Stanley Maintains ResMed (RMD) Overweight RecommendationOctober 20 - Fintel |
|
|
Here's Why ResMed (RMD) is a Strong Growth StockOctober 19 - Yahoo |
Wells Fargo Initiates Coverage of ResMed (RMD) with Equal-Weight RecommendationOctober 13 - Fintel |
|
|
ResMed (RMD): Exploring Valuation After Recent Share Price PullbackOctober 12 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 1.35B | 528M | 820M | 380M | 532M | 2.550 |
| Q1 '25 | 1.29B | 525M | 766M | 365M | 470M | 2.370 |
| Q4 '24 | 1.28B | 531M | 751M | 345M | 479M | 2.430 |
| Q3 '24 | 1.22B | 507M | 717M | 311M | 443M | 2.200 |
| Q2 '24 | 1.22B | 519M | 704M | 292M | 422M | 2.080 |
Insider Transactions View All
| Farrell Michael J. filed to sell 467,792 shares at $282.8. October 9 '25 |
| Rider Michael J filed to sell 11,327 shares at $274.4. October 2 '25 |
| Sandercock Brett filed to sell 86,745 shares at $274.4. October 3 '25 |
| Farrell Michael J. filed to sell 467,792 shares at $278.1. September 9 '25 |
| Sandercock Brett filed to sell 87,745 shares at $270.8. September 3 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kelly Louise Morrison |
Jun 19, 25 | Sell | $1K - $15K |
| Kelly Morrison |
May 14, 25 | Sell | $1K - $15K |
| Kelly Louise Morrison |
May 14, 25 | Sell | $1K - $15K |
Read more about Resmed (RMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Resmed?
The Market Cap of Resmed is $37.9B.
What is Resmed's PE Ratio?
As of today, Resmed's PE (Price to Earnings) ratio is 27.31.
When does Resmed report earnings?
Resmed will report its next earnings on October 30 '25.
What is the current stock price of Resmed?
Currently, the price of one share of Resmed stock is $259.21.
How can I analyze the RMD stock price chart for investment decisions?
The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.
Does RMD offer dividends to its shareholders?
Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.8%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Resmed?
Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.
